- Home
- BRBR vs TFX Comparison
BRBR vs TFX Comparison
Compare BRBR & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRBR
- TFX
- Stock Information
- Founded
- BRBR 2019
- TFX 1943
- Country
- BRBR United States
- TFX United States
- Employees
- BRBR N/A
- TFX N/A
- Industry
- BRBR Packaged Foods
- TFX Medical/Dental Instruments
- Sector
- BRBR Consumer Staples
- TFX Health Care
- Exchange
- BRBR Nasdaq
- TFX Nasdaq
- Market Cap
- BRBR 9.1B
- TFX 9.0B
- IPO Year
- BRBR 2019
- TFX N/A
- Fundamental
- Price
- BRBR $72.09
- TFX $192.21
- Analyst Decision
- BRBR Strong Buy
- TFX Buy
- Analyst Count
- BRBR 15
- TFX 9
- Target Price
- BRBR $67.86
- TFX $259.00
- AVG Volume (30 Days)
- BRBR 843.6K
- TFX 500.8K
- Earning Date
- BRBR 11-18-2024
- TFX 10-31-2024
- Dividend Yield
- BRBR N/A
- TFX 0.71%
- EPS Growth
- BRBR 45.78
- TFX N/A
- EPS
- BRBR 1.66
- TFX 5.03
- Revenue
- BRBR $1,913,000,000.00
- TFX $3,025,824,000.00
- Revenue This Year
- BRBR $21.49
- TFX $4.52
- Revenue Next Year
- BRBR $10.96
- TFX $4.92
- P/E Ratio
- BRBR $43.42
- TFX $38.13
- Revenue Growth
- BRBR 21.58
- TFX 2.27
- 52 Week Low
- BRBR $44.37
- TFX $189.95
- 52 Week High
- BRBR $73.27
- TFX $257.85
- Technical
- Relative Strength Index (RSI)
- BRBR 79.99
- TFX 25.96
- Support Level
- BRBR $70.12
- TFX $194.58
- Resistance Level
- BRBR $73.27
- TFX $200.15
- Average True Range (ATR)
- BRBR 1.39
- TFX 6.42
- MACD
- BRBR 0.33
- TFX -1.82
- Stochastic Oscillator
- BRBR 86.35
- TFX 4.60
About BRBR BellRing Brands Inc.
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders, and nutrition bars. The company's products are distributed through a diverse network of channels including club, food, drug and mass, eCommerce, convenience and specialty.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.